Device Trial Radar · NCT05251701
Personal KinetiGraph® Clinical Validation Study
Last checked: Nov 21, 2026Latest source record: Oct 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
19
Actual
Start
Dec 9, 2022
Primary completion
Aug 16, 2023
Study completion Sep 3, 2025
Sponsor
- Lead sponsor
- Global Kinetics CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 23, 2022
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to clinically validate new measures of the Personal KinetiGraph® (PKG®).
Conditions
- Movement Disorders
- Parkinson Disease
Interventions
Personal KinetiGraph® (PKG®) SystemDevice
The PKG® System includes a wrist-worn device that records and measures movement patterns in conditions such as Parkinson's disease.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluation of new PKG assessments to be clinically validated for Gait/walking using movement data collected from the PKG WatchTime frame: 2-3 years
6 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Tucson Neuroscience Research
Tucson, Arizona
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.